Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Active tuberculosis | x | x | x | x | x | x | x | x | x | ||||
Carcinoma | x | x | x | x | x | x | |||||||
Chronic peptic ulcer | x | x | x | ||||||||||
Diabetes mellitus | x | x | x | x | x | ||||||||
Extrapulmonary tuberculosis | x | ||||||||||||
Hodgkin's disease | x | x | x | x | x | ||||||||
Immunodeficiency | x | x | x | ||||||||||
Induration | x | x | x | x | x | x | x | x | x | ||||
Infection | x | x | x | ||||||||||
Leukaemia | x | x | x | x | x | x | |||||||
Low income | x | x | x | x | x | x | x | x | x | ||||
Malabsorption | x | x | x | x | x | x | |||||||
Malnutrition | x | x | x | x | x | x | x | ||||||
Renal failure chronic | x | x | x | x | x | ||||||||
Silicosis | x | x | x | x | x | x | x | x | x | ||||
Skin test reaction | x | x | x | x | x | x | x | x | |||||
Tuberculosis | x | x | x | x | x | x | x | x | x | ||||
Ulcer | x | x | x | ||||||||||
Weight decreased | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |